Company Description
GTRS is the ticker symbol associated with Gritstone Bio, a company referenced in regulatory information published by Valerio Therapeutics. In that disclosure, a member of the Board of Directors of Valerio Therapeutics is also described as a member of the Board of Directors of Gritstone Bio, identified with the Nasdaq ticker GTRS. This establishes GTRS as the market symbol historically linked to Gritstone Bio on Nasdaq.
The available information highlights a governance connection rather than a detailed operational profile. Gritstone Bio is mentioned in the context of board memberships held by a director of Valerio Therapeutics, alongside other listed and unlisted companies. Beyond confirming the association between Gritstone Bio and the symbol GTRS, no further details about its industry classification, sector, products, services, or business model are provided in the cited material.
Because the source data focuses on directorships and positions held in various organizations, it does not describe how Gritstone Bio operates, what markets it serves, or how it generates revenue. As a result, any deeper characterization of GTRS would go beyond the verified information. The most reliable takeaway from the available data is that GTRS represents Gritstone Bio on Nasdaq and that at least one individual serves on both the Valerio Therapeutics board and the Gritstone Bio board.
Investors and researchers looking into GTRS can treat this page as a starting point for understanding that the symbol is tied to Gritstone Bio and that there is a documented overlap in board-level governance between Gritstone Bio and Valerio Therapeutics. For more detailed insight into Gritstone Bio’s activities, strategy, or financial profile, additional primary sources beyond the provided disclosure would be required.
Stock Performance
Latest News
SEC Filings
No SEC filings available for GTRS.